Hemostemix Inc. Share Price
Stocks
HEM
CA4236943060
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Toronto S.E.
09:10:34 27/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.0800 CAD | +6.67% |
|
+6.67% | -11.11% |
| 20/08 | Hemostemix Commercializes Its Vascular Dementia Clinical Trial of Vescell(Tm) Under Larta | CI |
| 31/07 | Hemostemix Raises C$322,250 From Second Tranche of Private Placement | MT |
| Market Cap | 1.58Cr 1.14Cr 98.29L 92.29L 84.24L 108.62Cr 1.59Cr 11Cr 4.25Cr 55Cr 4.29Cr 4.19Cr 182.37Cr | P/E 2024 |
-4.36x | P/E 2025 | -3.12x |
|---|---|---|---|---|---|
| Enterprise Value | 1.87Cr 1.35Cr 1.16Cr 1.09Cr 99.47L 128.25Cr 1.88Cr 13Cr 5.02Cr 65Cr 5.06Cr 4.95Cr 215.33Cr | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
82.85% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +6.67% | ||
| 1 week | +6.67% | ||
| Current month | +33.33% | ||
| 1 month | +33.33% | ||
| 3 months | +45.45% | ||
| 6 months | -5.88% | ||
| Current year | -11.11% |
| 1 week | 0.07 |  | 0.08 |
| 1 month | 0.06 | | 0.08 |
| Current year | 0.04 | | 0.11 |
| 1 year | 0.04 | | 0.14 |
| 3 years | 0.04 | | 0.42 |
| 5 years | 0.04 | | 0.42 |
| 10 years | 0 | | 5.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Smeenk
CEO | Chief Executive Officer | - | 10/02/2020 |
Christina Wu
DFI | Director of Finance/CFO | - | 05/03/2020 |
Fraser Henderson
CTO | Chief Tech/Sci/R&D Officer | - | 14/10/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Smeenk
BRD | Director/Board Member | - | 26/11/2019 |
Ronnie Hershmann
BRD | Director/Board Member | 67 | 09/02/2020 |
Loran Swanberg
BRD | Director/Board Member | - | 08/04/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/07/26 | Option | Chairman | 5,25,000 | 0.2654% | ||
| 22/07/26 | Option | Director | 3,85,000 | 0.1946% | ||
| 22/07/26 | Option | Founder | 17,30,000 | 0.8746% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.67% | +6.67% | -27.27% | -33.33% | 1.14Cr | |
| -1.66% | -4.96% | +49.84% | +88.43% | 6.95TCr | |
| -2.19% | +1.32% | +44.54% | +88.38% | 6.5TCr | |
| -3.57% | -4.24% | +47.11% | +5.60% | 2.65TCr | |
| +1.59% | -2.89% | -17.14% | +450.02% | 2.59TCr | |
| -0.95% | -10.27% | +0.61% | -16.29% | 2.56TCr | |
| -9.71% | -0.36% | +245.87% | +377.68% | 2.02TCr | |
| -1.58% | +0.47% | +29.35% | -19.62% | 2TCr | |
| -3.36% | -7.58% | +9.47% | +535.81% | 1.57TCr | |
| -0.28% | -0.20% | +46.42% | +143.14% | 1.35TCr | |
| Average | -1.50% | -3.33% | +42.88% | +161.98% | 2.82TCr | |
| Weighted average by Cap. | -2.20% | -3.50% | +47.93% | +144.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -26.16L -18.87L -16.25L -15.26L -13.93L -18Cr -26.35L -1.81Cr -70.34L -9.11Cr -70.86L -69.32L -30Cr | -47.14L -34L -29.28L -27.49L -25.09L -32Cr -47.48L -3.26Cr -1.27Cr -16Cr -1.28Cr -1.25Cr -54Cr |
| Net Debt | 42.31L 30.52L 26.28L 24.67L 22.52L 29Cr 42.61L 2.92Cr 1.14Cr 15Cr 1.15Cr 1.12Cr 49Cr | 28.61L 20.64L 17.77L 16.68L 15.23L 20Cr 28.81L 1.98Cr 76.92L 9.96Cr 77.48L 75.8L 33Cr |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | CA$0.0800 | +6.67% | 59,001 |
| 26/26/26 | CA$0.0750 | +7.14% | 1,912 |
| 25/26/25 | CA$0.0700 | -6.67% | 1,300 |
| 24/26/24 | CA$0.0750 | 0.00% | 1,13,267 |
- Stock Market
- Stocks
- HEM Stock
Select your edition
All financial news and data tailored to specific country editions
